Component
Hepatic lipid-droplet degradation
Hepatic lipid-droplet degradation. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The protection required triglyceride breakdown through lipolysis and lipophagy, tested with Pnpla2 and Lipa inhibition.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/molybdenum-research/41641916.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "52b4d4d00867faaa1bb51ff6055f887a72c4c0d266bf7a1665b3780ce03aee64", "start_char": 0, "end_char": 1681, "text_sha256": "52b4d4d00867faaa1bb51ff6055f887a72c4c0d266bf7a1665b3780ce03aee64"}
- experimental_model
- Global/liver Mtarc1 knockout with Pnpla2, Lipa, Pemt and Cept1 interventions
- exposure
- Diet-induced liver disease with gene knockouts/knockdowns and multi-omics
- limitations
- Preclinical mechanism; no evidence that dietary molybdenum restriction selectively reproduces MTARC1 targeting.
- nutrient_topic
- Molybdenum research collection; topical membership is not evidence of a direct dietary effect. · Molybdenum
- organism
- Mus musculus; supporting cell studies
- plain_language
- Fat had to be broken down for the protective effect to occur.
- primary_references
- [mo-p41641916] MTARC1 Inactivation Remodels Lipid Droplets to Protect Against Metabolic Fatty Liver Disease. (2026). https://pubmed.ncbi.nlm.nih.gov/41641916/ DOI: 10.1111/liv.70539
- tissue_or_cell_type
- Hepatic lipid droplets
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Molybdenum: cofactor assembly, sulfur metabolism and nutrient interactions (2026-09-17) · lines 1574–1585
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Global/liver Mtarc1 knockout with Pnpla2, Lipa, Pemt and Cept1 interventions · source_derived_draft · unverified_draft
### mo-marc-lipolysis The protection required triglyceride breakdown through lipolysis and lipophagy, tested with Pnpla2 and Lipa inhibition. Condition category: machinery_impairment nutrient_topic: Molybdenum research collection; topical membership is not evidence of a direct dietary effect. plain_language: Fat had to be broken down for the protective effect to occur. organism: Mus musculus; supporting cell studies tissue_or_cell_type: Hepatic lipid droplets experimental_model: Global/liver Mtarc1 knockout with Pnpla2, Lipa, Pemt and Cept1 interventions limitations: Preclinical mechanism; no evidence that dietary molybdenum restriction selectively reproduces MTARC1 targeting. exposure: Diet-induced liver disease with gene knockouts/knockdowns and multi-omics evidence_span: {"source_cache": "artifacts/molybdenum-research/41641916.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "52b4d4d00867faaa1bb51ff6055f887a72c4c0d266bf7a1665b3780ce03aee64", "start_char": 0, "end_char": 1681, "text_sha256": "52b4d4d00867faaa1bb51ff6055f887a72c4c0d266bf7a1665b3780ce03aee64"} [mo-p41641916] MTARC1 Inactivation Remodels Lipid Droplets to Protect Against Metabolic Fatty Liver Disease. (2026). https://pubmed.ncbi.nlm.nih.gov/41641916/ DOI: 10.1111/liv.70539
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.